medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 20252026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends.
Closing the "Vitamin Add-On" Loophole For a long time, some pharmacies argued that adding Vitamin B12 or other ingredients created a "new" medication that wasn't a copy of the brand name
General self-injection preparation, site rotation, and disposal guidance
$64.99 $102.99Price range: $64.99 through $102.99 BPC-157 Spray provides research-grade BPC-157 (Body Protective Compound-157) in a nasal spray formulation, enabling intranasal delivery for research protocols investigating CNS, neurological, or systemic effects via mucosal absorption
New Zealand | In depth: The people who were first in line might not be the people who urgently need it Researchers noticed in diabetes trials that patients on semaglutide were losing significant amounts of weight, so Novo Nordisk, the company that owns Ozempic, began testing the drug for indications of weight loss specifically